Glaxo to Pay $3 Billion for Unapproved Marketing of Paxil & Wellbutrin
In agreeing to settle the largest case of health care fraud in U.S. history, GlaxoSmithKline pled guilty today to marketing Paxil for teens and...
Call for a Federal Investigation into the Link between Psychotropic Drugs and Mass Murder
In response to the Sandy Hook Elementary School shooting, ISEPP, a non-profit mental health research and education network, issues a statement calling for a...
Shire Refocuses ADHD Drug To Treat Binge Eating
Shire, dissatisfied with the success - but not "resounding success" - of its amphetamine/amino acid combination Vyvanse, is developing the drug (which recently failed...
“How Open Data Can Improve Medicine”
“Those who possess the data control the story.” In the wake of the reanalysis of the infamous Study 329, where scientific data claiming the antidepressant Paxil was safe and effective for teens was egregiously manipulated, researchers are pushing for open access to raw data. “The issue here, scientists argue, is that without independent confirmation, it becomes too easy to manipulate data.”
Forest Labs’ Antidepressant Marketing Woes Continue
Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even...
“Controversial Paxil Paper Still Under Fire 13 Years Later”
From Wednesday's Brown Daily Herald: "Two weeks ago, Edmund Levin and George Stewart, members of the American Academy of Child and Adolescent Psychiatry, sent...
“What Can A Rat’s ‘Behavioral Despair’ Tell You?”
"A 'tail suspension test' is exactly what its title implies. Researchers lift a rat by the tail for a few minutes at a time,...
Landmark Zoloft Hearing
A first-of-its-kind hearing in Texas will determine how future court cases linking SSRIs with congenital malformation will be handled. Pfizer, the manufacturer of Zoloft,...
Closing Arguments Start Today in California “Zoloft Defense” Case
The trial of former California police officer Anthony Orban for rape goes to closing arguments today. Orban is pleading "not guilty by reason of...
Consumer Reports Recommends Against Antipsychotics for Depression
Consumer Reports recommends against antipsychotic "augmentation therapy" for depression. The consumer watchdog magazine finds that the unproven efficacy, harmful side effects, availability of alternatives,...
Tenacity Pays Off For a Swedish Journalist
Bob Fiddaman writes about Janne Larsson, whose dogged journalism brought to light closely-guarded information that revealed the true extent of antidepressant-related suicides associated with...
“Depression Experts Question Effectiveness of Stress Hormone Drug”
Pioneering research by mood disorder experts at Newcastle University has questioned the effectiveness of metyrapone, a drug suggested to treat depression. "Our research has...
Who Determines Efficacy?
1 Boring Old Man reflects on his work with children and adolescents, in which he directly observes the troubling effects of antidepressants, and the...
No Evidence For Antidepressants in Depression With Dementia
In a review and meta-analysis of double-blind, placebo-controlled, randomly-assigned trials of antidepressants marketed in the U.S., researchers at the University of California failed to...
“Legal Marijuana, Antidepressants, and the Danger of not Listening”
Dr. Claudia Gold of Boston.com comments on the recent research finding that "thoughts of suicide, sexual difficulties and emotional numbness as a result of anti-depressants...
“Rush to Prescribe: Study Questions Speed in Giving Antidepressants to Grieving Parents”
MedicalXpress and Science 2.0 interview MiA blogger Jeffrey Lacasse about his recent paper, "Prescribing of Psychiatric Medication to Bereaved Parents Following Perinatal/Neonatal Death: An Observational Study."
Article →
The Antidepressant Solution
Book by Joseph Glenmullen, a "Step-by-Step Guide to Safely Overcoming Antidepressant Withdrawal, Dependence and 'Addiction.'"
Go to Amazon         ...
“Zoloft Defense” Defendant Testifies on His Own Behalf
Anthony Orban, the defendant in a California trial for kidnap and rape, who is claiming that a Zoloft-driven psychosis rendered him unaware of his...
Summary of Recent Antidepressant Meta-Analyses
On his own website, clinical psychologist Kenneth Pope has summarized 60 meta-analyses of antidepressants published between 2013-2015. The studies contain information on antidepressants “uses,...
Senator Pursues Questionable Pharma/Academic Ties
Senator Chuck Grassley continues his pursuit of questionable financial ties between the pharmaceutical companies and research by asking the National Institutes of Health (NIH)...
Jury Awards $3M to Family of 5-Year-Old With Topamax-Related Birth Defects
A Pennsylvania jury awarded $3 million to the family of a 5-year-old born with cleft palate and lip as a result of the mother...
Ohio to Review Antipsychotics in Foster and Other Children
The state of Ohio plans to invest $1 million in the next three years to review the use of psychiatric drugs prescribed to children,...
Efficacy & Effectiveness of Treatment for Depression in RCTs & Daily Practice
A study from the Netherlands found that outcomes for 598 patients in treatment for mild to moderate depression were significantly less in practice than...
“New Pill for Boosting Female Libidos Off to a Slow Start”
Ed Silverman reports that only 80 prescriptions for Addyi, or Flibanserin, were filled in the drugs’ first two weeks on the market.
Article →
Placebos In The News
A study that will appear in European Neuropsychopharmacology found that "the brain's response to the placebo pill seems to depend ... on whether or not...
